Mala Murthy - 19 Mar 2025 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role: CHIEF FINANCIAL OFFICER
Signature: /s/ Adam C. Vandervoort, Attorney-in-Fact
Issuer symbol: TDOC
Transactions as of: 19 Mar 2025
Net transactions value: -$173,416
Form type: 4
Filing time: 21 Mar 2025, 16:20:30 UTC
Previous filing: 04 Mar 2025
Next filing: 08 Apr 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TDOC	Common Stock	Options Exercise		+36,933	+37%		136,895	19 Mar 2025	Direct	F1
transaction	TDOC	Common Stock	Sale	$173,416	-20,586	-15%	$8.42	116,309	20 Mar 2025	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TDOC	Restricted Stock Units	Options Exercise	$0	-36,933	-33%	$0.000000	73,867	19 Mar 2025	Common Stock	36,933		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2	Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
F3	One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.